The current stock price of OFIX is 12.98 USD. In the past month the price decreased by -15%. In the past year, price decreased by -28.41%.
ChartMill assigns a fundamental rating of 2 / 10 to OFIX. Both the profitability and financial health of OFIX have multiple concerns.
Over the last trailing twelve months OFIX reported a non-GAAP Earnings per Share(EPS) of -1.08. The EPS decreased by -10900% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.31% | ||
| ROE | -26.92% | ||
| Debt/Equity | 0.39 |
11 analysts have analysed OFIX and the average price target is 23.26 USD. This implies a price increase of 79.17% is expected in the next year compared to the current price of 12.98.
For the next year, analysts expect an EPS growth of -23152% and a revenue growth 2.31% for OFIX
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.84 | 189.572B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.89 | 169.763B | ||
| SYK | STRYKER CORP | 24.17 | 137.985B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.69 | 135.821B | ||
| BDX | BECTON DICKINSON AND CO | 14.12 | 58.939B | ||
| IDXX | IDEXX LABORATORIES INC | 43.07 | 50.51B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.56 | 47.643B | ||
| RMD | RESMED INC | 21.35 | 36.698B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.64 | 35.886B | ||
| DXCM | DEXCOM INC | 28.44 | 27.937B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,616 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
ORTHOFIX MEDICAL INC
3451 Plano Pkwy
Lewisville TEXAS 75056 US
CEO: Jon Serbousek
Employees: 1616
Phone: 12149372000
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,616 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
The current stock price of OFIX is 12.98 USD. The price decreased by -0.38% in the last trading session.
OFIX does not pay a dividend.
OFIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
OFIX stock is listed on the Nasdaq exchange.
You can find the ownership structure of ORTHOFIX MEDICAL INC (OFIX) on the Ownership tab.
The outstanding short interest for ORTHOFIX MEDICAL INC (OFIX) is 2.76% of its float.